1. Preface

   • Jack E. Ansell

   EditorialNotes 13 September 2007 Pages: 1 - 1

2. Genetics in the context of thrombophilia

   • Elizabeth A. Varga

   Events 19 October 2007 Pages: 2 - 5

3. Genetic counseling for inherited thrombophilias

   • Elizabeth A. Varga

   OriginalPaper 19 October 2007 Pages: 6 - 9

4. Warfarin monitoring: point-of-care INR testing limitations and interpretation of the prothrombin time

   • Alan K. Jacobson

   OriginalPaper 15 November 2007 Pages: 10 - 11

5. Incorporating patient self-testing into your practice

   • Diane Wirth

   OriginalPaper 29 September 2007 Pages: 12 - 13

6. Patient barriers and solutions for INR self-testing

   • Nancy L. Shapiro

   OriginalPaper 27 September 2007 Pages: 14 - 15

7. Patient self-testing for management of anticoagulation therapy: challenges

   • Mark W. Wurster

   OriginalPaper 27 September 2007 Pages: 16 - 17

8. Anticoagulation for mechanical heart valves: a role for patient based therapy

   • Robert W. Emery
   • Ann. M. Emery
   • Jay G. Shake

   OriginalPaper 04 December 2007 Pages: 18 - 25

   

9. Anticoagulation in atrial fibrillation: selected controversies including optimal anticoagulation intensity, treatment of intracerebral hemorrhage

   • Robert G. Hart
   • Maria I. Aguilar

   OriginalPaper 29 September 2007 Pages: 26 - 32

   

10. Cancer and venous thromboembolism: prevention, treatment and survival

    • Agnes Yuet Ying Lee

    OriginalPaper 29 September 2007 Pages: 33 - 36

11. Treatment of DVT: how long is enough and how do you predict recurrence

    • Giancarlo Agnelli
    • Cecilia Becattini

    OriginalPaper 01 October 2007 Pages: 37 - 44

    

12. Pharmacogenetics of warfarin: regulatory, scientific, and clinical issues

    • Brian F. Gage
    • Lawrence J. Lesko

    OriginalPaper 01 October 2007 Pages: 45 - 51

    

13. New oral Xa and IIa inhibitors: updates on clinical trial results

    • Sylvia Haas

    OriginalPaper 27 October 2007 Pages: 52 - 60

    

14. Determinants and measures of quality in oral anticoagulation therapy

    • Scott Kaatz

    OriginalPaper 29 September 2007 Pages: 61 - 66

15. Establishing an inpatient anticoagulation service: a step by step review

    • John Viercinski
    • Lynda Thomson
    • Geno J. Merli

    OriginalPaper 29 September 2007 Pages: 67 - 71

    

16. Dietary supplements, herbs and oral anticoagulants: the nature of the evidence

    • Ann K. Wittkowsky

    OriginalPaper 29 September 2007 Pages: 72 - 77

17. Case studies in anticoagulation management

    • Wendy A. Leong

    OriginalPaper 01 October 2007 Pages: 78 - 84

18. Managing anticoagulant related coagulopathy

    • Amir K. Jaffer

    OriginalPaper 17 October 2007 Pages: 85 - 90

19. Utilization of dietary vitamin K supplementation to aid in INR stabilization for patients on chronic oral anticoagulant therapy: a series of case reports

    • L. Earl
    • R. Pena
    • J. Hutchinson

    Events 04 November 2007 Pages: 91 - 91

20. Utilization of vitamin K in an outpatient anticoagulation clinic

    • Sharon Starling
    • Karen Knoell
    • Lynn Shaffer

    Events 04 December 2007 Pages: 92 - 92

21. Low dose daily vitamin K supplementation in patients anticoagulated with warfarin

    • M. E. Lang
    • C. M. Hartig
    • R. T. Weibert

    Events 15 November 2007 Pages: 93 - 93

22. Use of daily vitamin K supplementation in patients on warfarin with a history of frequent dose changes or variable INRs

    • S. K. Ford
    • C. P. Misita
    • S. Moll

    Events 15 November 2007 Pages: 94 - 94

23. Effect of low-dose vitamin K supplementation in patients on warfarin with fluctuating international normalized ratios

    • B. Sipe
    • L. Heyerly
    • D. Kaminskas

    Events 08 November 2007 Pages: 95 - 95

24. Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin

    • K. Woods
    • J. D. Douketis
    • M. Crowther

    Events 15 November 2007 Pages: 96 - 96

25. Clinical practice of supplemental vitamin K therapy in patients on oral anticoagulants with unstable international normalized ratios: a questionnaire-based study

    • Stephan Moll

    Events 16 November 2007 Pages: 97 - 97

26. Pharmacogentic factors affecting INR control during warfarin initiation

    • Charles S. Eby
    • Jenine K. Harris
    • Elena Birman-Deych

    Events 16 November 2007 Pages: 98 - 98

27. Evaluation of commercial platforms for rapid genotyping of polymorphisms affecting therapeutic warfarin dose

    • Charles S. Eby
    • Rhonda-Porche-Sorbet
    • Brian Gage

    Events 14 November 2007 Pages: 99 - 99

28. Pharmacogenetic dose adjustments in orthopedic patients beginning warfarin therapy

    • Petra A. Jacobsen-Lenzini
    • Charles S. Eby
    • Brian F. Gage

    Events 08 November 2007 Pages: 100 - 100

29. Common clinical variables predict warfarin maintenance dose and therapeutic resistance

    • Bryce A. Kerlin
    • Spero Cataland
    • Mark Wurster

    Events 16 November 2007 Pages: 101 - 101

30. Optimal dose adjustment in orthopedic patients beginning warfarin therapy

    • P. A. Jacobsen
    • G. R. Grice
    • B. F. Gage

    Events 16 November 2007 Pages: 102 - 102

31. Evaluation of warfarin (W) patient information

    • B. Bartle
    • A. Diamantouros
    • L. Kim

    Events 16 November 2007 Pages: 103 - 103

32. Frequent point of care monitoring demonstrates the safety of low intensity warfarin therapy in Asian patients with mechanical heart valve

    • Soumaya El Rouby

    Events 17 November 2007 Pages: 104 - 104

33. Implementing a computerized teaching tool to maximize patient education

    • Jane Holmes

    Events 17 November 2007 Pages: 105 - 105

34. Implementation of six sigma and lean methodology into the anticoagulation management process

    • B. Hurley
    • T. Taylor
    • E. Hahn

    Events 08 November 2007 Pages: 106 - 106

35. An observational evaluation of inpatient warfarin utilization and management

    • K. Phillips
    • M. Miscioscia
    • T. Trujillo

    Events 16 November 2007 Pages: 107 - 107

36. A benchmark comparison across USA anticoagulation centers using the dawn anticoagulation software

    • Syd Stewart
    • Louise Pearson

    Events 16 November 2007 Pages: 108 - 108

37. National experience with an electronic medical record for anticoagulation therapy

    • J. Woyach
    • M. Wurster

    Events 20 November 2007 Pages: 109 - 110

38. Azathioprine induced warfarin resistance: case reports and potential interaction mechanism

    • M. Amato
    • S. Mantha
    • N. Tsapatsaris

    Events 07 November 2007 Pages: 111 - 111

39. A randomized, double-blind trial of the interaction between cranberry juice and warfarin

    • Jack Ansell
    • Maryellen McDonough
    • David J. Greenblatt

    Events 08 November 2007 Pages: 112 - 112

40. Clinical challenges of management of a coumarin rodenticide (brodifacoum) toxicity vs. warfarin toxicity: case report

    • T. Lovejoy
    • A. Jacobson
    • S. Jacob

    Events 07 November 2007 Pages: 113 - 113

41. Evaluation of warfarin prescription labels

    • S. Jacob
    • A. Jacobson
    • C. Miller

    Events 07 November 2007 Pages: 114 - 114

42. Using an access database to manage a large multi-site anticoagulation population to generate outcome data

    • Keri Justice
    • Marjorie Showalter
    • John Winiecki

    Events 15 November 2007 Pages: 115 - 115

43. Risk of thromboembolism with short-term interruption of warfarin

    • David A. Garcia
    • Susan Regan
    • Elaine M. Hylek

    Events 17 November 2007 Pages: 116 - 116

44. A disease management protocol for outpatient bridging therapy with enoxaparin in patients requiring temporary interruption of long-term oral anticoagulation

    • S. R. Maciejewski
    • T. Ward
    • L. Swartz

    Events 07 November 2007 Pages: 117 - 117

45. Utilization of outpatient treatment of deep vein thrombosis and barriers to its use

    • Susan Fugate
    • Paula Gander

    Events 08 November 2007 Pages: 118 - 118

46. Effect of mandatory electronic order set on the ordering of DVT prophylaxis in medical patients: a prospective and retrospective study

    • E. Taiwo
    • J. Sobieraj
    • J. Ansell

    Events 16 November 2007 Pages: 119 - 119

47. Prevalent etiologies of non-therapeutic warfarin anticoagulation in a network of pharmacist-managed anticoagulation clinics

    • B. Cryder
    • M. Felczak
    • P. Gutierrez

    Events 07 November 2007 Pages: 120 - 120

48. An analysis of anticoagulant adverse drug events in a large community teaching hospital

    • Z. Khudeira
    • Satish Jain

    Events 15 November 2007 Pages: 121 - 121

49. Warfarin usage in octogenarians: report from a long-term care anticoagulation service with point of care INR testing & community pharmacists

    • Wendy A. Leong
    • Maria Ton
    • John Tse

    Events 15 November 2007 Pages: 122 - 122

50. Comparison of patient outcomes among Alaska native people using a warfarin dosing algorithm versus patient management system software

    • R. B. Boyle
    • B. D. Schilling

    Events 15 November 2007 Pages: 123 - 123